Adirondack Trust Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $237K | Sell |
1,872
-55
| -3% | -$7.25K | 0.07% | 138 |
|
|
2026
Q1 | $269K | Buy |
1,927
+135
| +8% | +$18.9K | 0.09% | 124 |
|
|
2025
Q4 | $220K | Sell |
1,792
-30
| -2% | -$3.65K | 0.07% | 137 |
|
|
2025
Q3 | $202K | Hold |
1,822
| – | – | 0.07% | 143 |
|
|
2025
Q2 | $202K | Hold |
1,822
| – | – | 0.07% | 139 |
|
|
2025
Q1 | $204K | Hold |
1,822
| – | – | 0.08% | 140 |
|
|
2024
Q4 | $168K | Sell |
1,822
-106
| -5% | -$9.54K | 0.06% | 154 |
|
|
2024
Q3 | $162K | Sell |
1,928
-202
| -9% | -$15.4K | 0.06% | 158 |
|
|
2024
Q2 | $146K | Hold |
2,130
| – | – | 0.06% | 161 |
|
|
2024
Q1 | $156K | Hold |
2,130
| – | – | 0.07% | 150 |
|
|
2023
Q4 | $154K | Sell |
2,130
-100
| -4% | -$7.78K | 0.07% | 147 |
|
|
2023
Q3 | $167K | Sell |
2,230
-425
| -16% | -$32.7K | 0.08% | 139 |
|
|
2023
Q2 | $202K | Sell |
2,655
-30
| -1% | -$2.39K | 0.09% | 135 |
|
|
2023
Q1 | $223K | Hold |
2,685
| – | – | 0.11% | 130 |
|
|
2022
Q4 | $231K | Hold |
2,685
| – | – | 0.12% | 123 |
|
|
2022
Q3 | $166K | Sell |
2,685
-450
| -14% | -$28.4K | 0.09% | 134 |
|
|
2022
Q2 | $193K | Buy |
3,135
+425
| +16% | +$26.3K | 0.1% | 126 |
|
|
2022
Q1 | $161K | Buy |
2,710
+175
| +7% | +$11.2K | 0.08% | 133 |
|
|
2021
Q4 | $184K | Sell |
2,535
-275
| -10% | -$18.9K | 0.09% | 123 |
|
|
2021
Q3 | $183K | Hold |
2,810
| – | – | 0.09% | 124 |
|
|
2021
Q2 | $193K | Sell |
2,810
-40
| -1% | -$2.67K | 0.1% | 121 |
|
|
2021
Q1 | $184K | Hold |
2,850
| – | – | 0.1% | 120 |
|
|
2020
Q4 | $187K | Buy |
2,850
+40
| +1% | +$2.41K | 0.11% | 102 |
|
|
2020
Q3 | $177K | Hold |
2,810
| – | – | 0.12% | 100 |
|
|
2020
Q2 | $195K | Hold |
2,810
| – | – | 0.13% | 96 |
|
|
2020
Q1 | $210K | Sell |
2,810
-160
| -5% | -$11.1K | 0.17% | 85 |
|
|
2019
Q4 | $187K | Sell |
2,970
-285
| -9% | -$18.6K | 0.12% | 98 |
|
|
2019
Q3 | $207K | Hold |
3,255
| – | – | 0.15% | 88 |
|
|
2019
Q2 | $220K | Hold |
3,255
| – | – | 0.15% | 90 |
|
|
2019
Q1 | $212K | Sell |
3,255
-317
| -9% | -$21.1K | 0.15% | 92 |
|
|
2018
Q4 | $223K | Sell |
3,572
-823
| -19% | -$57.5K | 0.17% | 88 |
|
|
2018
Q3 | $340K | Sell |
4,395
-795
| -15% | -$60K | 0.23% | 77 |
|
|
2018
Q2 | $368K | Sell |
5,190
-1,086
| -17% | -$76.7K | 0.26% | 70 |
|
|
2018
Q1 | $453K | Sell |
6,276
-745
| -11% | -$59.2K | 0.32% | 65 |
|
|
2017
Q4 | $503K | Sell |
7,021
-170
| -2% | -$12.9K | 0.37% | 61 |
|
|
2017
Q3 | $582K | Sell |
7,191
-405
| -5% | -$31K | 0.46% | 51 |
|
|
2017
Q2 | $538K | Sell |
7,596
-900
| -11% | -$59.9K | 0.43% | 53 |
|
|
2017
Q1 | $577K | Sell |
8,496
-3,635
| -30% | -$256K | 0.4% | 58 |
|
|
2016
Q4 | $868K | Sell |
12,131
-569
| -4% | -$42.3K | 0.6% | 44 |
|
|
2016
Q3 | $1M | Buy |
12,700
+290
| +2% | +$23.6K | 0.72% | 37 |
|
|
2016
Q2 | $1.03M | Sell |
12,410
-50
| -0.4% | -$4.44K | 0.74% | 36 |
|
|
2016
Q1 | $1.14M | Sell |
12,460
-40
| -0.3% | -$3.61K | 0.85% | 32 |
|
|
2015
Q4 | $1.04M | Buy |
12,500
+729
| +6% | +$75.9K | 0.82% | 33 |
|
|
2015
Q3 | $1.16M | Sell |
11,771
-110
| -0.9% | -$12.2K | 0.93% | 30 |
|
|
2015
Q2 | $1.39M | Buy |
11,881
+290
| +3% | +$31.7K | 1.04% | 25 |
|
|
2015
Q1 | $1.14M | Buy |
11,591
+140
| +1% | +$14.2K | 0.85% | 36 |
|
|
2014
Q4 | $1.08M | Buy |
11,451
+2,930
| +34% | +$303K | 0.81% | 36 |
|
|
2014
Q3 | $907K | Sell |
8,521
-65
| -0.8% | -$6.37K | 0.69% | 40 |
|
|
2014
Q2 | $712K | Sell |
8,586
-1,375
| -14% | -$107K | 0.54% | 43 |
|
|
2014
Q1 | $706K | Buy |
9,961
+275
| +3% | +$21.6K | 0.56% | 43 |
|
|
2013
Q4 | $727K | Buy |
9,686
+275
| +3% | +$19.1K | 0.59% | 43 |
|
|
2013
Q3 | $592K | Sell |
9,411
-1,775
| -16% | -$106K | 0.52% | 50 |
|
|
2013
Q2 | $573K | Buy |
+11,186
| New | +$583K | 0.52% | 49 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
Adirondack Trust Company's GILD Position: Q2 2026 in Review
Adirondack Trust Company reduced its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, selling an estimated $7.25K and leaving 1,872 shares worth $237K. The position accounts for 0.07% of the portfolio, ranked #138.
Adirondack Trust Company first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.39M in Q2 2015. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Adirondack Trust Company held 1,872 shares of Gilead Sciences worth $237K as of Q2 2026.
- Adirondack Trust Company sold 55 Gilead Sciences shares in Q2 2026, an estimated $7.25K.
- Gilead Sciences made up 0.07% of Adirondack Trust Company's portfolio in Q2 2026, its #138 holding.
- Adirondack Trust Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Adirondack Trust Company's Gilead Sciences position peaked at $1.39M in Q2 2015.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.